| Name | Title | Contact Details |
|---|---|---|
Robert Freeberg |
Vice President Procurement | Profile |
Mark Christopulos |
R&D Portfolio - Senior Director | Profile |
Philippe Samama |
VP, New Product Strategy & Planning | Profile |
Nathalie Dubois-Stringfellow |
Senior Vice President, Product Development and Management | Profile |
Mark Edwards |
Senior Director, Supply Chain Management | Profile |
ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies.
In Vivo Scientific is a Valley Park, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IDRI is a nonprofit biotech organization taking a comprehensive approach to develop new solutions for infectious disease. We combine the high-quality science of a research or academic organization with the product development capabilities of a life science company, including an onsite GMP manufacturing facility.
Dante Labs is a global genomic data company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing. Headquartered in Cambridge, United Kingdom, with a research laboratory in Wolverhampton, Dante Labs supported the UK Government`s urgent requirement to scale-up a high-capacity, highly automated testing solution for Covid-19, including infected patients as well as those with antibodies. Dante Labs was able to deliver by leveraging existing technology that had been developed for whole genome sequencing.